LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | SU11274 | 0.04 | uM | LJP5 | 1.1201 | 0.0316 | 1.2033 | 0.0567 |
| SK-BR-3 | SB590885 | 0.04 | uM | LJP5 | 1.1238 | 0.0082 | 1.2055 | 0.0133 |
| Hs 578T | SB590885 | 0.12 | uM | LJP5 | 1.1559 | 0.0303 | 1.2073 | 0.0457 |
| SK-BR-3 | SB590885 | 0.37 | uM | LJP5 | 1.1244 | 0.0097 | 1.2080 | 0.0225 |
| SK-BR-3 | SB590885 | 1.11 | uM | LJP5 | 1.1253 | 0.0129 | 1.2083 | 0.0227 |
| Hs 578T | SB590885 | 1.11 | uM | LJP5 | 1.1546 | 0.0559 | 1.2085 | 0.0785 |
| Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 1.1546 | 0.0561 | 1.2089 | 0.0793 |
| Hs 578T | SB590885 | 3.33 | uM | LJP5 | 1.1567 | 0.0721 | 1.2128 | 0.0987 |
| SK-BR-3 | Nilotinib | 0.37 | uM | LJP5 | 1.1290 | 0.0113 | 1.2149 | 0.0225 |
| SK-BR-3 | CP466722 | 0.04 | uM | LJP5 | 1.1311 | 0.0127 | 1.2161 | 0.0090 |
| SK-BR-3 | XL147 | 3.33 | uM | LJP5 | 1.1328 | 0.0271 | 1.2180 | 0.0407 |
| Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 1.1702 | 0.0722 | 1.2312 | 0.1010 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 1.1502 | 0.0432 | 1.2445 | 0.0668 |
| Hs 578T | SB590885 | 0.04 | uM | LJP5 | 1.1873 | 0.0255 | 1.2483 | 0.0422 |
| BT-20 | Enzastaurin | 10.0 | uM | LJP5 | 1.1895 | 0.0305 | 1.2746 | 0.0438 |